Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1859431Generated: November 4, 2026

(r)-5,11-Dihydro-5-[1-[3-(4-methoxyphenyl)propyl]piperidine-2-ylmethyl]dibenzo[b,e][1,4]oxazepine → (r)-5,11-Dihydro-5-[1-[3-(4-methoxyphenyl)propyl]piperidine-2-ylmethyl]dibenzo[b,e][1,4]oxazepine hydrochloride

https://huagongshe.com/reaction/1859431

Reaction equation

Participants

RoleNameHCIDCharge
Reactant(r)-5,11-Dihydro-5-[1-[3-(4-methoxyphenyl)propyl]piperidine-2-ylmethyl]dibenzo[b,e][1,4]oxazepineHCID 12018618—
ReactantHydrogen chloride-ethyl acetateHCID 21866389—
SolventDichloromethaneHCID 6344—
Product(r)-5,11-Dihydro-5-[1-[3-(4-methoxyphenyl)propyl]piperidine-2-ylmethyl]dibenzo[b,e][1,4]oxazepine hydrochlorideHCID 69900804—

Reaction Steps

1.0 ml of 4 M hydrochloric acid/ethyl acetate was added to a solution of (R)-5,11-dihydro-5-[1-[3-(4-methoxyphenyl)propyl]piperidine-2-ylmethyl]dibenzo[b,e][1,4]oxazepine (196 mg) in dichloromethane (5 ml), and they were stirred for 2 hours. The solvent was evaporated under reduced pressure. The title compound was obtained in the form of a light yellow solid (180 mg, 85%).

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS06528504B2
Source datasetuspto-grants-2003_03
ORD IDord-9e946c50541f457e98952d84e89bbe98
Source noteuspto-grants-2003_03